Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Neurotoxicology|January 1, 1990
Neurotoxicology dose/response assessment for several cholinesterase inhibitors: use of uncertainty factorsK C Raffaele, C ReesBehavioral Neuroscience|June 1, 1988
Hippocampal and amygdaloid involvement in working memory for nonspatial stimuliK C Raffaele, D S OltonNIDA Research Monograph|January 1, 1990
Long-term effects of cholinergic agonists on memoryD S Olton, K C RaffaeleToxicology and Applied Pharmacology|May 1, 1986
Behavioral consequences of intraperitoneal carbon monoxide administration in ratsS B Fountain, K C Raffaele, Z AnnauNeurotoxicology and Teratology|April 29, 2004
A qualitative retrospective analysis of positive control data in developmental neurotoxicity studiesK M Crofton, S L Makris, W F Sette, et al.Psychopharmacology Bulletin|January 1, 1991
Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer typeK C Raffaele, A Berardi, S Asthana, et al.Psychopharmacology|January 1, 1993
Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's diseaseT T Soncrant, K C Raffaele, S Asthana, et al.Alzheimer Disease and Associated Disorders|June 18, 1999
Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer diseaseS Asthana, K C Raffaele, N H Greig, et al.Alzheimer Disease and Associated Disorders|January 1, 1995
Treatment of Alzheimer disease by continuous intravenous infusion of physostigmineS Asthana, K C Raffaele, A Berardi, et al.Clinical Pharmacology and Therapeutics|September 1, 1995
Clinical pharmacokinetics of physostigmine in patients with Alzheimer's diseaseS Asthana, N H Greig, L Hegedus, et al.Pageof 2